Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA revision label on the page updated from v3.6.5 to v3.6.6, representing a minor version update to the page.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a software or UI update to the page.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page footer has been updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a platform/UI update without altering the study information or eligibility details.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page shows a new revision tag at the bottom, indicating an update to the study page (v3.6.3). This is a maintenance update and does not change the study details.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page shows a new revision tag (v3.6.2) replacing the previous v3.6.0, indicating a software update to the page without altering study information.SummaryDifference0.0%

- Check94 days agoChange DetectedNew help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label appeared; the older Intervention / Treatment label and the Revision: v3.5.5 tag were removed in favor of Revision: v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.